Inventor · disambiguated record
Wheeseong Lee
Also filed as: LEE WHEESEONG
7 granted patents·4 pending applications·267 citations·filing 1998–2008
87Inventor score
Top patents by PatentIndex Score
11 records- 0196US6140351AOrtho-anthranilamide derivatives as anti-coagulantsBERLEX LAB·Filed 1998·Granted Oct 31, 2000·179 cites·50 claims
- 0291US6380221B1Ortho-anthranilamide derivatives as anti-coagulantsBERLEX LAB·Filed 2000·Granted Apr 30, 2002·33 cites·5 claims
- 0384US7776896B25-cyano-prostacyclin derivatives as agents for the treatment of influenza a viral infectionBAYER SCHERING PHARMA AG·Filed 2008·Granted Aug 17, 2010·7 cites·10 claims
- 0483US6498185B1Ortho-anthranilamide derivatives as anti-coagulantsBERLEX LAB·Filed 2000·Granted Dec 24, 2002·14 cites·17 claims
- 0582US7220856B2Substituted quinoline CCR5 receptor antagonistsSCHERING AG·Filed 2003·Granted May 22, 2007·22 cites·8 claims
- 0674US7105563B2Indolinone derivatives and their use in treating disease-states such as cancerSCHERING AG·Filed 2004·Granted Sep 12, 2006·10 cites·15 claims
- 0767US8198456B2Dihydropyridine derivatives as useful as protein kinase inhibitorsADLER MARC·Filed 2007·Granted Jun 12, 2012·2 cites·10 claims
- 0852US2008242713A1Novel 5-cyano-prostacyclin derivatives as agents for the treatment of autoimmune diseasesGUILFORD WILLIAM·Filed 2008·Application pending·0 cites
- 0945US2005101644A1Benzylether amine compounds useful as CCR-5 antagonistsSCHERING AG·Filed 2004·Application pending·0 cites
- 1041US2007129359A1Tetrahydronaphthalene derivatives, processes for their preparation and their use as antiinflammatory agentsHUWE CHRISTOPH·Filed 2006·Application pending·0 cites
- 1138US2006167044A1Piperidine derivatives and their use as anti-inflammatory agentsARNAIZ DAMIAN O·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wheeseong Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →